Growing Incidence Of Autoimmune Disorders Fuels The Market: Key Factor Driving The Growth In The Addison's Disease Market

We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

What Is the Expected Addison's Disease Market Size During the Forecast Period?
In the past few years, there has been a swift expansion in the market size of Addison's disease. It is projected to escalate from $2.05 billion in 2024 to $2.25 billion in 2025, with a compound annual growth rate (CAGR) of 10.0%. The historic surge in the market can be linked to a global increase in Addison's disease cases, heightened awareness about adrenal insufficiency, elevation in health care spending, a climbing prevalence of autoimmune diseases, and an enlarging elderly population.

The market for Addison's disease is projected to expand robustly in the upcoming years, with its value anticipated to reach $3.26 billion by 2029, growing at a Compound Annual Growth Rate (CAGR) of 9.7%. The evolution during the predicted period can be credited to factors such as the growing demand for sophisticated therapies, rising focus on early detection, increased instances of congenital adrenal hyperplasia, the expansion of telemedicine services, and a rising number of adrenal tuberculosis cases. Key trends projected for this period incorporate the progress in lab testing techniques, improvements in hormone replacement therapies, advancements in imaging technologies, the advent of long-term injectable formulations, and the integration of artificial intelligence into diagnostic tools.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21084

What Are the High-Growth Segments in the Addison's Disease Market?
The addison's disease market covered in this report is segmented -

1) By Type: Primary Adrenal Insufficiency, Secondary Adrenal Insufficiency, Tertiary Adrenal Insufficiency
2) By Drug Class: Oral Corticosteroid, Hydrocortisone, Fludrocortisone, Corticosteroid Injections
3) By Diagnosis: Laboratory Testing, Imaging Testing
4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

Subsegments:
1) By Primary Adrenal Insufficiency: Autoimmune Addison's Disease, Infectious Addison's Disease, Other causes of primary adrenal insufficiency
2) By Secondary Adrenal Insufficiency: Pituitary gland dysfunction, Hypothalamic dysfunction
3) By Tertiary Adrenal Insufficiency: Hypothalamic or pituitary suppression due to long-term steroid use, Other causes of tertiary adrenal insufficiency

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21084&type=smp

What Key Drivers Are Expected to Influence Future Addison's Disease Market Growth?
The rise in the occurrence of autoimmune diseases is poised to boost the development of the market for Addison's disease in the future. Autoimmune diseases appear when the body's own immune system mistakenly assaults the body's healthy tissues, triggering inflammation and damage. Factors like genetic predispositions, environmental elements such as pollutants, changes in diet, and lifestyle factors like stress and lack of regular exercise all play a role in the escalation of autoimmune diseases. The increasing frequency of autoimmune diseases heightens the probability of having Addison's disease simultaneously, as many patients also develop other autoimmune conditions. For example, the Germany-based organization, Versorgungsatlas.de reported in November 2024 that in 2022, of the 73,241,305 insured people, 6,304,340 got diagnosed with a minimum of one autoimmune disease, translating to a raw prevalence rate of 8.61%. This figure surpasses the prior estimates, which ranged from 3% to 9%. Therefore, the escalating occurrence of autoimmune diseases is fueling the expansion of the Addison's disease market.

Which Companies Hold the Largest Share Across Different Addison's Disease Market Segments?
Major companies operating in the addison's disease market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., Bayer AG, Bristol-Myers Squibb Company, Novartis AG, Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Amgen Inc., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Sandoz, Ipsen S.A., Neurocrine Biosciences Inc., Recipharm AB, Accord Healare, Eton Pharmaceuticals, DuoCort Pharma, Diurnal Group plc, Roxane Laboratories Inc.

What Trends Are Driving Growth in The Addison's Disease Market?
Leading firms active in the Addison's disease market are turning their attention to innovative solutions such as regenerative therapies. Such therapies can enhance treatment methodologies, improve patient recovery rates, and ideally diminish the perpetual reliance on hormone replacement therapies, by restoring the body's intrinsic adrenal functions. Regenerative therapies involve medical strategies that aim at repairing or regenerating human cells, tissues, or organs. These strategies aspire to reestablish normal functioning and accelerate healing in instances of injury, disease, or organ decay. For example, Eton Pharmaceuticals, Inc., an American pharmaceutical public company that specialises in the development and commercialisation of novel treatments for rare illnesses, declared in July 2024 that the FDA had accepted its New Drug Application (NDA) for ET-400. This is an exclusive formulation of hydrocortisone oral solution which is simpler to store and transport compared to other formulas requiring refrigeration. Moreover, its liquid format caters to the needs of younger patients who might struggle with swallowing traditional tablets and facilitates exact dosing.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/addisons-disease-global-market-report

What Are the Emerging Geographies for The Addison's Disease Market Growth?
North America was the largest region in the addison's disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the addison's disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Addison's Disease Market?
2. What is the CAGR expected in the Addison's Disease Market?
3. What Are the Key Innovations Transforming the Addison's Disease Industry?
4. Which Region Is Leading the Addison's Disease Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.